NASDAQ:OBIO - Nasdaq - US68572M1062 - Common Stock - Currency: USD
OBIO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of OBIO have multiple concerns. While showing a medium growth rate, OBIO is valued expensive at the moment.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -112.3% | ||
ROE | -393.4% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 92.58% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.85 | ||
Debt/FCF | N/A | ||
Altman-Z | -9.04 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 3.35 | ||
Quick Ratio | 3.34 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
3.34
+0.03 (+0.91%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 44.34 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 7.59 | ||
P/tB | 7.59 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -112.3% | ||
ROE | -393.4% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 92.58% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.85 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 313.88% | ||
Cap/Sales | 34.48% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 3.35 | ||
Quick Ratio | 3.34 | ||
Altman-Z | -9.04 |